Reuters logo
Australian drug company Mayne Pharma Group fall more than 16 percent
December 15, 2016 / 11:36 PM / a year ago

Australian drug company Mayne Pharma Group fall more than 16 percent

SYDNEY, Dec 16 (Reuters) - Shares in Australian pharmaceutical company Mayne Pharma Group Ltd fell more than 16 percent on Friday, after opening 8 percent down, on news that 20 U.S states had filed legal proceedings against the company, alleging illegal conspiracies that raised prices on two common generic drugs.

Reporting by Colin Packham; Editing by Michael Perry

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below